首届神经介入外科学会神经介入肿瘤学峰会报告
中枢神经系统肿瘤治疗进展有限,胶质母细胞瘤和弥漫性内生性脑桥胶质瘤等恶性肿瘤预后仍差。神经介入外科学会于2024年4月26-27日在休斯顿德克萨斯大学MD安德森癌症中心召开首届神经介入肿瘤学峰会,汇集神经介入医师、神经外科医师、神经肿瘤学家、神经放射学家、基础科学家和行业代表,报告该新兴领域的实践现状及建立组织平台以治疗中枢神经系统癌症并推进研究的努力。
要点
- 中枢神经系统肿瘤治疗25年来进展有限,胶质母细胞瘤和弥漫性内生性脑桥胶质瘤等恶性肿瘤预后仍差。
- 利用血管内神经介入技术和脑血管途径进行治疗递送是神经肿瘤学的新兴方向,多项选择性动脉内临床试验正在进行。
- 钇-90、溶瘤病毒和细胞免疫治疗等新型治疗剂正在作为动脉内治疗进行测试。
核心结论
- 血管内外科神经肿瘤学是一门新兴临床事业,旨在为中枢神经系统癌症提供新的治疗选择;多学科合作与协作将是该事业成功的关键。
研究设计与样本
- 神经介入外科学会召集的首届神经介入肿瘤学峰会于2024年4月26-27日在休斯顿德克萨斯大学MD安德森癌症中心举行;参会者包括神经介入医师、神经外科医师、神经肿瘤学家、神经放射学家、基础科学家和行业代表。
临床应用与阅片要点
- 影像模态的技术进步、选择性血脑屏障开放方法以及装置和导管将有助于推动该领域发展。
- 多学科合作与协作将是该事业成功的关键。
局限性
- 过去25年中枢神经系统肿瘤治疗进展有限。
- 胶质母细胞瘤和弥漫性内生性脑桥胶质瘤等恶性肿瘤的预后仍差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Over the past 25 years, progress in the treatment of CNS tumors has been limited, and outcomes for malignancies, such as glioblastoma and diffuse intrinsic pontine glioma, remain dismal. There has been great interest in harnessing endovascular neurointerventional techniques and using the cerebral vasculature as a route for therapeutic delivery in neuro-oncology. Several selective intra-arterial clinical trials are currently underway targeting a range of CNS tumors with different therapeutic agents. The Society of NeuroInterventional Surgery (SNIS) convened the inaugural Neurointerventional Oncology Summit, which was held on April 26-27, 2024, at the University of Texas MD Anderson Cancer Center in Houston, Texas. The group consisted of neurointerventionists, neurosurgeons, neuro-oncologists, neuroradiologists, basic scientists, and industry representatives who are current practitioners in this emerging space. We report the current state of practice and our efforts to develop an organizational platform to treat patients with CNS cancers and to advance research in this emerging field. Endovascular surgical neuro-oncology is an emerging clinical endeavor that aims to provide novel therapeutic options for CNS cancers. Novel therapeutic agents, including yttrium-90, oncolytic viruses, and cellular immunotherapy, are being tested as intra-arterial therapy. Technological advances in imaging modalities, selective methods of BBB opening, and devices and catheters will aid the advancement of the field. Multidisciplinary cooperation and collaboration will be integral to the success of this endeavor.
引用
- Young CC, Narsinh KH, Chen SR, et al. A Report from the Inaugural Society of NeuroInterventional Surgery Neurointerventional Oncology Summit. AJNR Am J Neuroradiol. 2026. PMID: 40592540. doi:10.3174/ajnr.A8902
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。